Merck Price Negotiation Lawsuit May Face Same Obstacles as 340B Takings Claims
Past 340B litigation highlights that takings challenges to the Medicare price negotiation program face an uphill battle.
medicare part b
-
Read more: Merck Price Negotiation Lawsuit May Face Same Obstacles as 340B Takings Claims -
Read more: The Ongoing Step Therapy Debate The Ongoing Step Therapy Debate
Senator Lisa Murkowski’s reintroduction of the Safe Step Act has revived the debate over the prudence of step therapy protocols.
-
Read more: The Promise and Pitfalls of Trump’s “Most Favored Nation” Approach to Drug Pricing The Promise and Pitfalls of Trump’s “Most Favored Nation” Approach to Drug Pricing
A recent executive order aimed at addressing ballooning pharmaceutical expenditures is ambitious in scope, but its impact remains to be seen.
